All sessions by topic

02. Building new treatment paradigms for TB programmes using PK/PD science

03. Developing counselling skill for TB caregivers in one day

04. An introduction to tuberculosis modelling (TB Modelling and Analysis Consortium)

05. Challenges in setting up phase 2/3 MDR-TB clinical trials

06. Ensuring MDR-TB patient information and adherence counselling is a key part of patient-centred care

07. Update on clinical and programmatic management of MDR- and XDR-TB

08. Integrating palliative care into the continuum of MDR-TB Care

09. Post-2015 GTB technical support coordination for Global Fund grants and concept notes for End TB Strategy

10. Application of programme guidelines for community-driven projects to eliminate TB among migrants

Union Working Group meeting: TB and mental health

Union Working Group meeting: TB and migration

13. Strengthening TB case finding and prevention in high-risk populations

13. Challenges of DR-TB treatment in India and opportunities beyond 2015: patient voices from India

Union Working Group meeting: TB education and training

Union Working Group meeting: TB, HIV and tobacco

16. Pharmacovigilance for bedaquiline, delamanid and other TB drugs and regimens

Research for the rest of us (Eng/Zul/Xho) I: The End TB Strategy

01. Discover the benefits of TB immunodiagnostics in programmatic use: evidence and real-world experience (Sponsored session, not accredited for CME credit)

02. Around the world vulnerability takes many forms

The State of TB and HIV on the 27th anniversary of World AIDS Day: Panel Discussion

03. Drug-resistant TB: outcomes - I

02. Best practice in management of side effects among DR-TB patients to improve quality of care | en français

04. Law enforcement and awareness

04. LTBI: a potpourri

05. Collaborative services for TB and diabetes

05. Financing TB services

06. TB surveillance from Swaziland to Japan

07. Tuberculosis: from the bench to the grave

07. Role of surgery in management of TB: a promise or redundancy?

09. HIV and lung health

09. Public-private strategies to End TB: the case of India

10. Using media for communications on TB

09. The cost of TB and lung health interventions: methodologies and implications for health systems and patients

11. Basic science: bugs and drugs

12. TB diagnostic challenges: molecular and other techniques

12. Managing pharmacovigilance systems: optimising the rational use of new TB medicines and novel regimens

14. Gene mutation: the engine behind drug resistance and TB strain diversity

14. Spelunking for treasure: searching for candidate biomarkers as prognostic indicators for treatment outcome

16. Retaining our patients in care

16. Scaling up MDR-TB services in resource-limited settings: progress and challenges from the field | en français

17. Maximizing opportunities for integrating TB services into maternal and child health programmes

18. Five years of Xpert MTB/RIF implementation: lessons learnt for increasing the impact of future new diagnostics

20. TB in children: diagnosis

20. The unaddressed health challenge of TB in prisons: applying End TB Strategy concepts of patient-centred care

22. A community-based approach to reaching the missing "three million"

24. Engagement of CSOs, communities and patients in TB control and management

The Mask: A play performed by the PEP Street Theatre Project

26. WHO/ERS initiative on e/mHealth in tuberculosis and tobacco control

Research for the rest of us (Eng/Zul/Xho) II: Advances in TB research

Tackling tuberculosis in key affected populations

06. Preventing infection and transmission of TB in health facilities and the community

08. High-definition insights into drug-resistant tuberculosis

10. The neglected cousins: trends and treatment of non-tuberculous mycobacteria

12. MDR-TB: impacts of detection and early treatment | en français

Friends of Pakistan - Closed Meeting

15. When waves trump paper: the triumph of e-technology

17. TB & NCD co-morbidity

26. TART: TB risk and impact of ART

28. Drug-resistant TB: epidemiology and transmission

29. LTBI testing, perceptions and epidemiology

30. Collaborative services for TB and diabetes

30. Eliminating the burden of TB in indigenous populations

31. High-burden, neglected patients: addressing the intersection of tuberculosis and mental disorders

34. Thinking broadly to advance the END TB Strategy

35. Financial impact of TB

35. Controversies and critical issues in clinical trial design for TB

37. Rapid diagnosis the world over

38. Phenotypes and genotypes: deciphering resistance development

39. Tuberculosis drug resistance and susceptibility testing in a nutshell

41. Stepping up patient access and support

42. Inside the belly of the beast: TB in correctional settings

43. The urban-rural divide: different places, similar issues

42. TB research and communities: ethical and practical considerations | en français

44. Achieving quality Xpert MTB/RIF use for rapid case detection

46. Strengthening community systems: building the evidence for impact

49. Strategies to improve TB-HIV screening and service integration

49. Sanatoria: back to the future?

52. Developing a rights-based approach to prevention and treatment of tuberculosis

02. How to reach the END of TB

04. TB epidemiology: from Malawi to Taiwan

05. Training for the fight against TB

8. Highlights and updates of diagnostic research for tuberculosis: where are we, what next? – Grant Theron (South Africa)

13. Case finding and contact tracing

15. From TB diagnosis to outcomes, and everything in between

22. The nature of the beast: emerging molecular information about mycobacteria

25. Engagement of CSOs, communities and patients in TB management and control

50. TB tidbits: diagnosis, surgery and outcomes

52. Community-based and self-administered treatment of drug-resistant TB

54. TB and nutrition

55. Molecular epidemiology and modelling: how can we break the cycle of transmission?

54. Critical updates on the treatment of TB-HIV co-infected children

58. Advancing the END TB strategy and other policy issues

57. The role of cost-effectiveness in achieving the End TB Strategy

60. Imagining and prediction rules for TB diagnosis

59. HIV/TB Late-Breaker Session | en français

60. Moving past clinic-based care: practical steps to improve TB care through community engagement | en français

61. Progress in clinical trials for TB treatment: 2015

62. Innovative approach to improving access and quality of care for DR-TB: implementing the ECHO telehealth model

64. TB contact investigation in high-risk populations: innovative approaches and implementation experiences

67. The spectrum of life: miners, drug users, the elderly

68. Paediatric TB: IPT, contact tracing and child perspectives

70. The 2 'Ts': linking TB and tobacco